People
Ben Wiegand
Ben Wiegand, PhD, was an independent director of Virtual Therapeutics Corporation in its May31,2024 primary legal roster. That filing identifies him as Lore Health Chief Scientific Officer sinceJune2023 and a founding partner of Connected World Without Disease Accelerator since2022, following Optum Labs SVP R&D2020–2022 and25years of increasingly senior Johnson & Johnson roles. Those included Janssen global leadership of World Without Disease Accelerator2017–2020 and Disease Interception Accelerator2014–2017. He has a chemistry undergraduate degree from the University of Illinois and MA/PhD in Physical Chemistry from Harvard. The SEC calls his undergraduate degree BA while an earlier J&J biography calls it BS; the degree field is retained without resolving that conflict. Current parent board service and an authentic original portrait are not verified.
Roles
Independent Director (last confirmed May2024)